Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Alzheimer's Disease

Free Subscription Articles published in Curr Alzheimer Res Retrieve available abstracts of 154 articles: HTML format

Single Articles

October 2025
1. WANG R, Yang X
   Research Progress on the Pathogenesis, Therapeutic Strategies, and Phthalocyanine Compounds for Alzheimer's Disease.
   Curr Alzheimer Res. 2025 Oct 2. doi: 10.2174/0115672050406141250822082635.
   PubMed     Abstract available
   
   
   September 2025
2. PAVITHRA R, Kanimozhi NV, Sonali L, Suneetha C, et al
   Unveiling Role of Gut Microbiota in Alzheimer's Disease: Mechanisms, Challenges and Future Perspectives.
   Curr Alzheimer Res. 2025 Sep 16. doi: 10.2174/0115672050403066250904112611.
   PubMed     Abstract available
   
   
   
3. BOUDI A, He J, Abd El Kader I, Liu X, et al
   Advancing Alzheimer's Disease Diagnosis Using VGG19 and XGBoost: A Neuroimaging-Based Method.
   Curr Alzheimer Res. 2025 Sep 15. doi: 10.2174/0115672050393604250904081342.
   PubMed     Abstract available
   
   
   
4. DUTTA A, Phukan BC, Roy R, Bhattacharya P, et al
   Arsenic Exposure Induces Cognitive Impairment in Mice with Increased Acetylcholinesterase Activity and Inflammation in the Cortex and Hippocampus: Implications for Alzheimer's Disease.
   Curr Alzheimer Res. 2025 Sep 8. doi: 10.2174/0115672050390649250904100840.
   PubMed     Abstract available
   
   
   
5. ALGAZZAWI H, Abujamai J, Alshanberi AM, Satar R, et al
   Role of GSK-3 Inhibition in Alzheimer's Disease Therapy.
   Curr Alzheimer Res. 2025 Sep 5. doi: 10.2174/0115672050400781250904082943.
   PubMed     Abstract available
   
   
   
6. ZHOU SY, Lin HX, Tang JM, Yao QY, et al
   The Association between the rs6656401 Locus of the CR1 Gene and Structural Alterations of Brain Effects in Han Chinese Patients with Alzheimer's Disease.
   Curr Alzheimer Res. 2025 Sep 4. doi: 10.2174/0115672050397092250823195514.
   PubMed     Abstract available
   
   
   
7. LEE S, Foo J, Yong Y, Daniel Looi Q, et al
   Network Pharmacology of miR-146a-5p as a Potential Anti-Inflammatory Agent in Preventing Alzheimer's Disease.
   Curr Alzheimer Res. 2025 Sep 3. doi: 10.2174/0115672050383519250825060815.
   PubMed     Abstract available
   
   
   August 2025
8. BEHROUZINIA S, Khanteymoori A
   Topological Biomarkers of Alzheimer's Disease from Functional Brain Network Analysis.
   Curr Alzheimer Res. 2025 Aug 26. doi: 10.2174/0115672050399190250815070642.
   PubMed     Abstract available
   
   
   
9. AMINE JM, Mourad M
   Multimodal Deep Learning Approaches for Early Detection of Alzheimer's Disease: A Comprehensive Systematic Review of Image Processing Techniques.
   Curr Alzheimer Res. 2025 Aug 7. doi: 10.2174/0115672050401817250721190509.
   PubMed     Abstract available
   
   
   
10. VARSHNEY H, Gaur K, Subhan I, Fatima J, et al
    Neuroprotective Effects of Fenugreek Leaf Extract in a Drosophila Model of Alzheimer's Disease Expressing Human Abeta-42.
    Curr Alzheimer Res. 2025 Aug 7. doi: 10.2174/0115672050385870250721072643.
    PubMed     Abstract available
    
    
    
11. ALKAF MS, Said MA, Algamdi NA, Al-Kaff NS, et al
    Unveiling the Potential Role of Cathinone and Cathine Compounds in Alzheimer's Disease: Predictive Insights.
    Curr Alzheimer Res. 2025 Aug 1. doi: 10.2174/0115672050386584250718130948.
    PubMed     Abstract available
    
    
    July 2025
12. XING Z, Jiang X, Yang W, Wang Y, et al
    Lithium Chloride Improves Electrophysiological and Memory Deficits in Rats with Streptozotocin-Induced Alzheimer's Disease.
    Curr Alzheimer Res. 2025 Jul 31. doi: 10.2174/0115672050399032250715043316.
    PubMed     Abstract available
    
    
    
13. POSZWA J, Slowikowski B, Owecki W, Szymanowicz O, et al
    Integration of Neuroimaging and Molecular Biomarkers in the Diagnosis of Alzheimer's Disease and Frontotemporal Dementia: The Promise of fMRI.
    Curr Alzheimer Res. 2025 Jul 31. doi: 10.2174/0115672050390340250716061313.
    PubMed     Abstract available
    
    
    
14. WEN J, Hu J, Yang X, Luo F, et al
    Effective Analysis of Alzheimer's Disease and Mechanisms of Methyl-4- Hydroxybenzoate using Network Toxicology, Molecular Docking, and Machine Learning Strategies.
    Curr Alzheimer Res. 2025 Jul 15. doi: 10.2174/0115672050399031250623062112.
    PubMed     Abstract available
    
    
    
15. CASTILLO-VELAZQUEZ R, Castaneda-Delgado JE, Garcia-Hernandez MH, Rivas-Santiago B, et al
    Identification of MicroRNA Drug Targets for Alzheimer's and Diabetes Mellitus Using Network Medicine.
    Curr Alzheimer Res. 2025 Jul 14. doi: 10.2174/0115672050393875250626065205.
    PubMed     Abstract available
    
    
    
16. WANG W, Huang X, Xu Z, Yu C, et al
    The Interaction between Oligodendrocytes and Abeta in Alzheimer's Disease.
    Curr Alzheimer Res. 2025 Jul 7. doi: 10.2174/0115672050401966250625171338.
    PubMed     Abstract available
    
    
    
17. RATHEE S, Pandey V, Soni S, Sen D, et al
    Comprehending Alzheimer's Disease: Molecular Mechanisms and Treatment Strategies.
    Curr Alzheimer Res. 2025 Jul 4. doi: 10.2174/0115672050368798250626075628.
    PubMed     Abstract available
    
    
    
18. PLUTA R, Kocki J, Kocka AB, Bogucki J, et al
    Alterations of Mitophagy (BNIP3), Apoptosis (CASP3), and Autophagy (BECN1) Genes in the Frontal Cortex in an Ischemic Model of Alzheimer's Disease with Long-Term Survival.
    Curr Alzheimer Res. 2025 Jul 2. doi: 10.2174/0115672050385480250619045022.
    PubMed     Abstract available
    
    
    June 2025
19. LUCA A, Politis A, Luca M, Ferri R, et al
    Serum Biomarkers of Vascular Dysfunction, Neuropsychiatric Symptoms, and Clinical Severity of Alzheimer's Disease: A Cross-sectional Study.
    Curr Alzheimer Res. 2025 Jun 25. doi: 10.2174/0115672050384313250612045355.
    PubMed     Abstract available
    
    
    
20. AMSAVALLI K, Suba Raja SK, Sudha S
    RESIGN: Alzheimer's Disease Detection Using Hybrid Deep Learning based Res-Inception Seg Network.
    Curr Alzheimer Res. 2025 Jun 18. doi: 10.2174/0115672050373821250612053943.
    PubMed     Abstract available
    
    
    
21. SINGH K, Gupta JK, Lakhchora G, Jain D, et al
    Advance Nanotechnology-Based Drug Delivery Systems for Alzheimer's Disease: Advancements and Future Perspectives.
    Curr Alzheimer Res. 2025 Jun 5. doi: 10.2174/0115672050380959250530112247.
    PubMed     Abstract available
    
    
    
22. KUMAR D, Anand P, Singh S
    Proposed Therapeutic Strategy to Combat Alzheimer's Disease by Targeting Beta and Gamma Secretases.
    Curr Alzheimer Res. 2025 Jun 5. doi: 10.2174/0115672050380899250602042028.
    PubMed     Abstract available
    
    
    
23. KENICHE A, Kalache C, Dib MEA, El Ouar I, et al
    Assessment of the Inhibition of AChE and BChE by Carthamus caeruleus Essential Oil and Carline Oxide: Neuroprotective Effects and In Vivo Toxicity Assessment for the Management of Alzheimer's Disease.
    Curr Alzheimer Res. 2025 Jun 5. doi: 10.2174/0115672050383227250529072253.
    PubMed     Abstract available
    
    
    
24. GANDHI P, Panchal S
    Exploring the Neuroprotective Potential of Polyphenolic Compounds in Mitigating Quinolinic Acid-Induced Neurotoxicity in Alzheimer's Disease.
    Curr Alzheimer Res. 2025 Jun 5. doi: 10.2174/0115672050383383250529100802.
    PubMed     Abstract available
    
    
    May 2025
25. CHAUHAN BS, Singh YP, Poeggeler B, Singh SK, et al
    Therapeutic Advances in Alzheimer's Disease: Integrating Natural, Semi-Synthetic, and Synthetic Drug Strategies.
    Curr Alzheimer Res. 2025 May 29. doi: 10.2174/0115672050366727250513061730.
    PubMed     Abstract available
    
    
    
26. CHEN Y, Zhao J, Li C, Yao Y, et al
    Anthocyanidins Intake is Associated with Alzheimer's Disease Risk in Americans over 60 Years of Age: Data from NHANES 2007-2008, 2009-2010, and 2017-2018.
    Curr Alzheimer Res. 2025 May 29. doi: 10.2174/0115672050372100250512054404.
    PubMed     Abstract available
    
    
    
27. SHAFIGH E, Sadeghi G, Abbasi Jamat N, Hassanpour F, et al
    Evaluating the Therapeutic Effects of Oxytocin on Animal Model of Alzheimer's Disease: A Systematic Review.
    Curr Alzheimer Res. 2025 May 23. doi: 10.2174/0115672050386593250521064527.
    PubMed     Abstract available
    
    
    
28. KHOSRAVI MM, Parsaei H
    IoMT Requirements, Integrated Diagnosis, and Future Trends for Multimodal Early Detection of Alzheimer's Disease.
    Curr Alzheimer Res. 2025 May 21. doi: 10.2174/0115672050393916250520101258.
    PubMed    
    
    
    
29. KARADURAN K, Aydogdu A, Gelisin O, Gunpinar S, et al
    Predictive Value of Complete Blood Count Parameters for Alzheimer's Disease in Relation to Periodontal Status.
    Curr Alzheimer Res. 2025 May 19. doi: 10.2174/0115672050388220250511174043.
    PubMed     Abstract available
    
    
    
30. ZARETSKY DV, Zaretskaia MV
    The Framework for an Integrative Theory of Alzheimer's Disease.
    Curr Alzheimer Res. 2025 May 8. doi: 10.2174/0115672050381553250425062803.
    PubMed     Abstract available
    
    
    
31. SHRIVASTAVA SR, Bobhate PS
    Exploring the Role of Nutrition in Supporting Brain Health and Reducing the Risk of Alzheimer's Disease.
    Curr Alzheimer Res. 2025 May 8. doi: 10.2174/0115672050397848250425060101.
    PubMed     Abstract available
    
    
    April 2025
32. KHOSROABADI Z, Niazmand A, Mousavi SR, Hosseini N, et al
    The Footprint of CHASERR as a Potential Culprit in Alzheimer's Disease Patients: An In-Silico-Experimental Study.
    Curr Alzheimer Res. 2025 Apr 28. doi: 10.2174/0115672050381537250422075255.
    PubMed     Abstract available
    
    
    
33. ZHONG J, Sun J, Zhou B
    Metabolic Regulation as a Potential Therapeutic Approach for Alzheimer's Disease.
    Curr Alzheimer Res. 2025 Apr 25. doi: 10.2174/0115672050379410250421065857.
    PubMed     Abstract available
    
    
    
34. AMERIZADEH F, Farzadifar E
    Unraveling the Intricacies: The Role of mRNAs in the Progression and Initiation of Alzheimer's Disease.
    Curr Alzheimer Res. 2025 Apr 23. doi: 10.2174/0115672050374376250416044512.
    PubMed     Abstract available
    
    
    
35. RODRIGUEZ-CASADO A, Alvarez MI, Merino JJ, Toledano-Diaz A, et al
    Relationship between Alzheimer's Disease and Type 2 Diabetes: Critical Review On Cellular and Molecular Common Pathogenic Mechanisms.
    Curr Alzheimer Res. 2025 Apr 11. doi: 10.2174/0115672050375461250325074826.
    PubMed     Abstract available
    
    
    
36. LI C, Chen Y, Yao Y, Zhang Y, et al
    Analysis of the Relationship Between NLRP3 and Alzheimer's Disease in Oligodendrocytes based on Bioinformatics and In Vitro Experiments.
    Curr Alzheimer Res. 2025 Apr 9. doi: 10.2174/0115672050376534250310061951.
    PubMed     Abstract available
    
    
    February 2025
37. GULIN W, Oziemblewska M, Zajac-Lamparska L
    Use of Virtual Reality to Improve Spatial Orientation in Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review.
    Curr Alzheimer Res. 2025 Feb 26. doi: 10.2174/0115672050374807250224044204.
    PubMed     Abstract available
    
    
    
38. HUSSAIN MS, Khan Y, Fatima R, Maqbool M, et al
    Microglial Modulation in Alzheimer's Disease: Central Players in Neuroinflammation and Pathogenesis.
    Curr Alzheimer Res. 2025 Feb 19. doi: 10.2174/0115672050364292250113063513.
    PubMed     Abstract available
    
    
    
39. RADIN DP, Zhong S, Cerne R, Shoaib M, et al
    Preclinical Pharmacology of CX1837, a High-Impact Ampakine with an Improved Safety Margin: Implications for Treating Alzheimer's Disease and Ischemic Stroke.
    Curr Alzheimer Res. 2025 Feb 10. doi: 10.2174/0115672050365821250127055828.
    PubMed     Abstract available
    
    
    
40. EL HAJ M, Gallouj K, Antoine P, Chapelet G, et al
    Prospective Memory in Mobile: Using Smartphone-Based Calendars to Rehabilitate Prospective Memory in Patients with Alzheimer's Disease.
    Curr Alzheimer Res. 2025 Feb 10. doi: 10.2174/0115672050369534250127104933.
    PubMed     Abstract available
    
    
    
41. ZHANG DQ, Yang X, Niu HB, Sun XC, et al
    Visualization Analysis of Tau Protein in the Brain of Alzheimer's Disease: A Scoping Literature Review.
    Curr Alzheimer Res. 2025 Feb 3. doi: 10.2174/0115672050351995241223065923.
    PubMed     Abstract available
    
    
    January 2025
42. MIR M, Khosravani P, Ramezannezhad E, Saadabad FP, et al
    Association Between Metabolomics Findings and Brain Hypometabolism in Mild Alzheimer's Disease.
    Curr Alzheimer Res. 2025 Jan 28. doi: 10.2174/0115672050350196250110092338.
    PubMed     Abstract available
    
    
    
43. WANG C, Chen X, Yu Z
    Trafficking of Muscarinic 1 Acetylcholine Receptor Regulated by VPS35 in Alzheimer's Disease.
    Curr Alzheimer Res. 2025 Jan 28. doi: 10.2174/0115672050356990250111200217.
    PubMed     Abstract available
    
    
    
44. MEHRABADI S
    Extracellular Vesicles: A Promising Therapeutic Approach to Alzheimer's Disease.
    Curr Alzheimer Res. 2025 Jan 28. doi: 10.2174/0115672050365314250112042136.
    PubMed     Abstract available
    
    
    
45. GAO C, Pang X, Wang C, Huang J, et al
    Using Entropy as the Convergence Criteria of Ant Colony Optimization and the Application at Gene Chip Data Analysis.
    Curr Alzheimer Res. 2025;21:324-341.
    PubMed     Abstract available
    
    
    
46. SHYTLE RD, Tan J, Bickford PC, Rezaizadeh K, et al
    Retraction Notice: Optimized Turmeric Extract Reduces beta-Amyloid and Phosphorylated Tau Protein Burden in Alzheimer's Transgenic Mice.
    Curr Alzheimer Res. 2025;22:e300425241672.
    PubMed     Abstract available
    
    
    
47. CHENG W, Zhang J, Zhu H, Wang Z, et al
    NRN1 may Modulate Tau Phosphorylation and Neuronal Apoptosis in AD via the PIGU-CASP3 Axis.
    Curr Alzheimer Res. 2025;22:219-231.
    PubMed     Abstract available
    
    
    
48. ARAKI W
    Social Isolation as a Risk Factor for Dementia: Insights from Animal Model Studies.
    Curr Alzheimer Res. 2025;22:165-173.
    PubMed     Abstract available
    
    
    December 2024
49. LI K, Gao Y, Liu M, Chen Y, et al
    Advances in Alzheimer's Disease Biomarkers.
    Curr Alzheimer Res. 2024 Dec 26. doi: 10.2174/0115672050366767241223050957.
    PubMed     Abstract available
    
    
    
50. ZHANG K, Yang K, Yu G, Shi B, et al
    Development of a Novel Mitochondrial Dysfunction-Related Alzheimer's Disease Diagnostic Model Using Bioinformatics and Machine Learning.
    Curr Alzheimer Res. 2024 Dec 26. doi: 10.2174/0115672050353736241218054012.
    PubMed     Abstract available
    
    
    
51. ACAR M, Seker B, Ugur S
    Radio-Anatomical Assessment of Cerebellum Volume in Individuals with Alzheimer's Disease.
    Curr Alzheimer Res. 2024 Dec 26. doi: 10.2174/0115672050365323241217175349.
    PubMed     Abstract available
    
    
    
52. BHATTACHARYA K, Sungoh D, Kharmujai D, Islam A, et al
    Exploring the Therapeutic Potential of 8-Prenyldaidzein: A Comprehensive Study of its Multi-Target Efficacy in Alzheimer's Disease.
    Curr Alzheimer Res. 2024 Dec 23. doi: 10.2174/0115672050358848241211080546.
    PubMed     Abstract available
    
    
    
53. LIN F, Yang X, Li L, Chen J, et al
    The Relationship between Alzheimer's Disease and Ferroptosis: A Bibliometric Study Based on Citespace.
    Curr Alzheimer Res. 2024 Dec 23. doi: 10.2174/0115672050348799241211072746.
    PubMed     Abstract available
    
    
    
54. MISHRA AK, Srivastava A, Raj V, Saini V, et al
    Recent Updates on Alzheimer's Disease: Pathogenesis, Pathophysiology, Molecular Approaches and Natural Bioactive Compounds Used in Contemporary Time to Alleviate Disease.
    Curr Alzheimer Res. 2024 Dec 23. doi: 10.2174/0115672050361294241211071813.
    PubMed     Abstract available
    
    
    
55. WU D, Zhang B, Chang Y, Huang S, et al
    Apathy Associated with Alzheimer's Disease.
    Curr Alzheimer Res. 2024 Dec 23. doi: 10.2174/0115672050350970241216072400.
    PubMed     Abstract available
    
    
    
56. BOLSHAKOVA OI, Slobodina AD, Slepneva EE, Sarantseva SV, et al
    Acetyl-L-Carnitine Aids in Preservation of Cholinergic Neurons and Memory in the Drosophila melanogaster Model of Alzheimer's Disease.
    Curr Alzheimer Res. 2024 Dec 23. doi: 10.2174/0115672050347906241203075930.
    PubMed     Abstract available
    
    
    
57. NEVES RC, Figueiredo RC, Faria-Melibeu AC
    The Potential Role of Enrichment Environment on Plasticity in Alzheimer's Disease Models: Insights About Therapeutic Approaches.
    Curr Alzheimer Res. 2024 Dec 2. doi: 10.2174/0115672050348227241128095209.
    PubMed     Abstract available
    
    
    November 2024
58. JIA D, He T, Sun L, Wang Q, et al
    Molecular Signatures and Clinical Significance of Notch Signaling Pathway in Peripheral Blood of Patients with Alzheimer's Disease.
    Curr Alzheimer Res. 2024 Nov 29. doi: 10.2174/0115672050339307241108101528.
    PubMed     Abstract available
    
    
    
59. KIM S, Han DY, Bae J
    Transforming Alzheimer's Digital Caregiving through Large Language Models.
    Curr Alzheimer Res. 2024 Nov 25. doi: 10.2174/0115672050301740241118044604.
    PubMed     Abstract available
    
    
    
60. JIN J, Lu L, Hua K, Fang L, et al
    Correlations between SHBG, Sex Hormones, Inflammation, and Neurocognitive Decline in Alzheimer's Disease:A Retrospective Study.
    Curr Alzheimer Res. 2024 Nov 25. doi: 10.2174/0115672050341904241111082935.
    PubMed     Abstract available
    
    
    
61. CHEN Y, Li C, Yao Y, Shang Y, et al
    Identifying the Role of Oligodendrocyte Genes in the Diagnosis of Alzheimer's Disease through Machine Learning and Bioinformatics Analysis.
    Curr Alzheimer Res. 2024 Nov 6. doi: 10.2174/0115672050338777241028071955.
    PubMed     Abstract available
    
    
    October 2024
62. HUANG J, Pang X, Yang H, Gao C, et al
    Molecular Mechanisms of GFAP and PTPRC in Alzheimer's Disease: An Analysis of Neuroinflammatory Response and Progression.
    Curr Alzheimer Res. 2024 Oct 30. doi: 10.2174/0115672050333760241010061547.
    PubMed     Abstract available
    
    
    
63. KHAN AH, Ijaz E, Ubaid B, Eddaki I, et al
    Analysis of Alzheimer's Disease-Related Mortality Rates Among the Elderly Populations Across the United States: An Analysis of Demographic and Regional Disparities from 1999 to 2020.
    Curr Alzheimer Res. 2024 Oct 23. doi: 10.2174/0115672050338833240924113200.
    PubMed     Abstract available
    
    
    
64. SCIANATICO G, Manippa V, Zaca D, Jovicich J, et al
    Correlations between Cerebrospinal Fluid Biomarkers and Gray Matter Atrophy in Alzheimer's and Behavioural Variant Frontotemporal Dementia.
    Curr Alzheimer Res. 2024 Oct 22. doi: 10.2174/0115672050330903240919074725.
    PubMed     Abstract available
    
    
    September 2024
65. AYASSE ND, Stewart WF, Lipton RB, Gomez-Ulloa D, et al
    Post-Hoc Assessment of Cognitive Efficacy in Alzheimer's Disease Using a Latent Growth Mixture Model in AMBAR, a Phase 2B Randomized Controlled Trial.
    Curr Alzheimer Res. 2024 Sep 23. doi: 10.2174/0115672050316936240905064215.
    PubMed     Abstract available
    
    
    
66. SIVANESAN S, Howell MD, Kaushik V, Jayakumar R, et al
    Multifunctional Tasks and an Energy Crisis are Crucial Players in Determining the Vulnerability of the Entorhinal Cortex to Early Damage in Alzheimer's Disease.
    Curr Alzheimer Res. 2024 Sep 13. doi: 10.2174/0115672050324909240823104209.
    PubMed     Abstract available
    
    
    August 2024
67. ACAR M, Ugur S
    Morphometric Analysis of Corpus Callosum in Individuals with Alzheimer's Disease: Magnetic Resonance Imaging (MRI) Study.
    Curr Alzheimer Res. 2024 Aug 22. doi: 10.2174/0115672050335744240820065952.
    PubMed     Abstract available
    
    
    
68. RANJBAR S, Mehrabi M, Akbari V, Pashaei S, et al
    "Cyclophilin A" Enzymatic Effect on the Aggregation Behavior of 1N4R Tau Protein: An Overlooked Crucial Determinant that should be Re-considered in Alzheimer's Disease Pathogenesis.
    Curr Alzheimer Res. 2024 Aug 16. doi: 10.2174/0115672050330163240812050223.
    PubMed     Abstract available
    
    
    
69. HAMDI A, Baroudi S, Gharbi A, Babay W, et al
    Dysregulation of Porphyromonas gingivalis Agmatine Deiminase Expression in Alzheimer's Disease.
    Curr Alzheimer Res. 2024 Aug 13. doi: 10.2174/0115672050327009240808103542.
    PubMed     Abstract available
    
    
    
70. ALMEAQLI MT, Alaidaa Y, Alnajjar FM, Al Shararh AS, et al
    Therapeutic Effects of Arctiin on Alzheimer's Disease-like Model in Rats by Reducing Oxidative Stress, Inflammasomes and Fibrosis.
    Curr Alzheimer Res. 2024 Aug 12. doi: 10.2174/0115672050333388240801043509.
    PubMed     Abstract available
    
    
    
71. ZHANG W, Zhang L, Lv M, Fu Y, et al
    Advances in Developing Small Molecule Drugs for Alzheimer's Disease.
    Curr Alzheimer Res. 2024 Aug 12. doi: 10.2174/0115672050329828240805074938.
    PubMed     Abstract available
    
    
    July 2024
72. HURLA M, Banaszek N, Kozubski W, Dorszewska J, et al
    Alzheimer's Disease and Vascular Dementia, Connecting and Differentiating Features.
    Curr Alzheimer Res. 2024 Jul 29. doi: 10.2174/0115672050319219240711103459.
    PubMed     Abstract available
    
    
    
73. KUSHWAH S, Mani A
    Comprehensive Investigation of Natural Ligands as Inhibitors of beta Secretase to Identify Alzheimer's Disease Therapeutics.
    Curr Alzheimer Res. 2024 Jul 15. doi: 10.2174/0115672050323622240705043337.
    PubMed     Abstract available
    
    
    
74. SCARFO S, Moshfeghi Y, J McGeown W
    Assessing the Stability of Clusters of Neuropsychiatric Symptoms in Alzheimer's Disease and Mild Cognitive Impairment.
    Curr Alzheimer Res. 2024 Jul 15. doi: 10.2174/0115672050309014240705113444.
    PubMed     Abstract available
    
    
    
75. PLUTA R
    A Look at the Etiology of Alzheimer's Disease based on the Brain Ischemia Model.
    Curr Alzheimer Res. 2024 Jul 3. doi: 10.2174/0115672050320921240627050736.
    PubMed     Abstract available
    
    
    June 2024
76. OUYANG X, Collu R, Benavides G, Tian R, et al
    ROCK Inhibitor Fasudil Attenuates Neuroinflammation and Associated Metabolic Dysregulation in the Tau Transgenic Mouse Model of Alzheimer's Disease.
    Curr Alzheimer Res. 2024 Jun 21. doi: 10.2174/0115672050317608240531130204.
    PubMed     Abstract available
    
    
    
77. MALEKI SF, Yousefi M, Sobhi N, Jafarizadeh A, et al
    Artificial Intelligence in Eye Movements Analysis for Alzheimer's Disease Early Diagnosis.
    Curr Alzheimer Res. 2024 Jun 4. doi: 10.2174/0115672050322607240529075641.
    PubMed     Abstract available
    
    
    May 2024
78. SONG G, Wu H, Chen H, Zhang S, et al
    hdWGCNA and Cellular Communication Identify Active NK Cell Subtypes in Alzheimer's Disease and Screen for Diagnostic Markers through Machine Learning.
    Curr Alzheimer Res. 2024 May 28. doi: 10.2174/0115672050314171240527064514.
    PubMed     Abstract available
    
    
    
79. ALHARBI KM, Alshehri SA, Almarwani WA, Aljohani KK, et al
    Effects of Cycloastragenol on Alzheimer's Disease in Rats by Reducing Oxidative Stress, Inflammation, and Apoptosis.
    Curr Alzheimer Res. 2024 May 17. doi: 10.2174/0115672050315334240508162754.
    PubMed     Abstract available
    
    
    April 2024
80. HE X, Selesnick I, Zhu M
    Research Progress of Eye Movement Analyses and its Detection Algorithms in Alzheimer's Disease.
    Curr Alzheimer Res. 2024 Apr 24. doi: 10.2174/0115672050300564240416074025.
    PubMed     Abstract available
    
    
    
81. KALYAANAMOORTHY S, Opare SK, Xu X, Ganesan A, et al
    Post-Translational Modifications in Tau and Their Roles in Alzheimer's Pathology.
    Curr Alzheimer Res. 2024 Apr 15. doi: 10.2174/0115672050301407240408033046.
    PubMed     Abstract available
    
    
    
82. SEN D, Rathee S, Pandey V, Jain SK, et al
    Comprehensive Insights into Pathophysiology of Alzheimer's Disease: Herbal Approaches for Mitigating Neurodegeneration.
    Curr Alzheimer Res. 2024 Apr 15. doi: 10.2174/0115672050309057240404075003.
    PubMed     Abstract available
    
    
    March 2024
83. YU B, Wan G, Cheng S, Wen P, et al
    Disruptions of Gut Microbiota are Associated with Cognitive Deficit of Preclinical Alzheimer's Disease: A Cross-Sectional Study.
    Curr Alzheimer Res. 2024 Mar 25. doi: 10.2174/0115672050303878240319054149.
    PubMed     Abstract available
    
    
    
84. NAGORI K, Pradhan M, Sharma M, Ajazuddin, et al
    Current Progress on Central Cholinergic Receptors as Therapeutic Targets for Alzheimer's Disease.
    Curr Alzheimer Res. 2024 Mar 25. doi: 10.2174/0115672050306008240321034006.
    PubMed     Abstract available
    
    
    
85. GAJOWNICZEK-ALASA D, Szwajgier D, Baranowska-Wojcik E
    Plant Soup Formulations Show Cholinesterase Inhibition Potential in the Prevention of Alzheimer's Disease.
    Curr Alzheimer Res. 2024 Mar 22. doi: 10.2174/0115672050306101240321050146.
    PubMed     Abstract available
    
    
    
86. HASKOLOGLU IC, Erdag E, Sehirli AO, Uludag O, et al
    Beyond Conventional Therapies: Molecular Dynamics of Alzheimer's Treatment through CLOCK/BMAL1 Interactions.
    Curr Alzheimer Res. 2024 Mar 19. doi: 10.2174/0115672050301014240315065235.
    PubMed     Abstract available
    
    
    
87. YAO J, Kan B, Dong Z, Tang Z, et al
    Research Progress of Mitophagy in Alzheimer's Disease.
    Curr Alzheimer Res. 2024 Mar 12. doi: 10.2174/0115672050300063240305074310.
    PubMed     Abstract available
    
    
    
88. WEAVER D
    Drug Design for Alzheimer's Disease: Biologics vs. Small Molecules.
    Curr Alzheimer Res. 2024 Mar 8. doi: 10.2174/0115672050301583240307114452.
    PubMed     Abstract available
    
    
    
89. DE A, Mishra TK, Saraf S, Tripathy B, et al
    A Review onthe Use of Modern Computational Methods in Alzheimer's Disease-Detection and Prediction.
    Curr Alzheimer Res. 2024 Mar 8. doi: 10.2174/0115672050301514240307071217.
    PubMed     Abstract available
    
    
    
90. TEKADE A, Susar R, Kulkarni G, Surwade S, et al
    Nanostructured Lipid Carriers of Donepezil Hydrochloride for the Treatment of Alzheimer's Disease.
    Curr Alzheimer Res. 2024 Mar 5. doi: 10.2174/0115672050288659240229080535.
    PubMed     Abstract available
    
    
    February 2024
91. TEKADE A, Kadam P, Jagdale S, Surwade S, et al
    Exploring Potential of Nano-formulations in the Treatment of Alzheimer's Disease through Nasal Route.
    Curr Alzheimer Res. 2024 Feb 29. doi: 10.2174/0115672050290462240222092303.
    PubMed     Abstract available
    
    
    
92. CHERNOV Y
    Handwriting Markers for the Onset of Alzheimer's Disease.
    Curr Alzheimer Res. 2024 Feb 28. doi: 10.2174/0115672050299338240222051023.
    PubMed     Abstract available
    
    
    
93. MAZIERO MP, Rocha NP, Teixeira AL
    Antipsychotics in Alzheimer's Disease: Current Status and Therapeutic Alternatives.
    Curr Alzheimer Res. 2024 Feb 22. doi: 10.2174/0115672050287534240215052417.
    PubMed     Abstract available
    
    
    
94. RODRIGUES JFR, Rodrigues LP, Filho GGMA
    Alzheimer's Disease and Suicide: An Integrative Literature Review.
    Curr Alzheimer Res. 2024 Feb 22. doi: 10.2174/0115672050292472240216052614.
    PubMed     Abstract available
    
    
    
95. OOI H, Koriyama Y
    Toxic Advanced Glycation End Product-Dependent Alzheimer's Disease- Like Alternation in the Microtubule System.
    Curr Alzheimer Res. 2024 Feb 14. doi: 10.2174/0115672050288723240213053342.
    PubMed     Abstract available
    
    
    
96. GUO Y, Sun CK, Tang L, Tan MS, et al
    Microglia PTK2B/Pyk2 in the Pathogenesis of Alzheimer's Disease.
    Curr Alzheimer Res. 2024 Feb 6. doi: 10.2174/0115672050299004240129051655.
    PubMed     Abstract available
    
    
    January 2024
97. SHIM YS
    Follow-up Comparisons of Two Plasma Biomarkers of Alzheimer's Disease, Neurofilament Light Chain, and Oligomeric Abeta: A Pilot Study.
    Curr Alzheimer Res. 2024 Jan 30. doi: 10.2174/0115672050284054240119101834.
    PubMed     Abstract available
    
    
    
98. STOVER KR, Stafford PM, Damian AC, Pasangulapati JP, et al
    Development and Optimization of a Target Engagement Model of Brain IDO Inhibition for Alzheimer's Disease.
    Curr Alzheimer Res. 2024 Jan 26. doi: 10.2174/0115672050283199240111111801.
    PubMed     Abstract available
    
    
    
99. DING Q, Lamberts J, Konieczny AM, Bringedahl TB, et al
    Association of Autoimmune Disorders and Disease-modifying Antirheumatic Drugs with the Risk of Alzheimer's and/or Dementia: A Population Study Using Medicare Beneficiary Data.
    Curr Alzheimer Res. 2024 Jan 26. doi: 10.2174/0115672050289966240110041616.
    PubMed     Abstract available
    
    
    
100. MA W, Lu K, Liang HM, Zhang JY, et al
     Synapsin 1 Ameliorates Cognitive Impairment and Neuroinflammation in Rats with Alzheimer's Disease: An Experimental and Bioinformatics Study.
     Curr Alzheimer Res. 2024 Jan 11. doi: 10.2174/0115672050276594231229050906.
     PubMed     Abstract available
     
     
     
101. SAEZ JMG
     Drive My CAR-AD Research here, there and Everywhere.
     Curr Alzheimer Res. 2024;21:1-2.
     PubMed    
     
     
     
102. PADALA S, Setti S, Raymick J, Hanig J, et al
     Evaluation and Characterization of Modified K114 Method to Localize Plaques in Rodent and Plaques and Tangles in Human Brain Tissue.
     Curr Alzheimer Res. 2024;21:69-80.
     PubMed     Abstract available
     
     
     
103. BENTLEY JH, Broussard JI
     Multimodal Gamma Stimulation Improves Activity but not Memory in Aged Tgf344-AD Rats.
     Curr Alzheimer Res. 2024;20:769-777.
     PubMed     Abstract available
     
     
     
104. OLGUN Y, Poyraz CA, Bozluolcay M, Konukoglu D, et al
     Plasma Biomarkers in Neurodegenerative Dementias: Unrevealing the Potential of Serum Oxytocin, BDNF, NPTX1, TREM2, TNF-alpha, IL-1 and Prolactin.
     Curr Alzheimer Res. 2024;21:109-119.
     PubMed     Abstract available
     
     
     
105. MUMTAZ, Ahmed F, Rabbani SA, El-Tanani M, et al
     Tauopathy in AD: Therapeutic Potential of MARK-4.
     Curr Alzheimer Res. 2024;21:779-790.
     PubMed     Abstract available
     
     
     
106. ULLAH K, Almutairi MH, Abbas MN, Wahab A, et al
     Discovery of Selective beta-Secretase (BACE-1) Inhibitors by the Solid-Phase Synthesis of Small Molecular-sized Peptides.
     Curr Alzheimer Res. 2024;21:723-734.
     PubMed     Abstract available
     
     
     
107. CHAPLYGINA A, Zhdanova D
     Mitochondrial Fragmentation as a Key Driver of Neurodegenerative Disease.
     Curr Alzheimer Res. 2024;21:607-614.
     PubMed     Abstract available
     
     
     
108. SI Y, Meng B, Qi F
     Age- and Genotype-Dependent Effects of Chronic Nicotine on Presenilin1/2 Double Knockout Mice: From Behavior to Molecular Pathways.
     Curr Alzheimer Res. 2024;21:817-832.
     PubMed     Abstract available
     
     
     December 2023
109. XU J, Gou S, Huang X, Zhang J, et al
     Uncovering the Impact of Aggrephagy in the Development of Alzheimer's Disease: Insights Into Diagnostic and Therapeutic Approaches from Machine Learning Analysis.
     Curr Alzheimer Res. 2023 Dec 21. doi: 10.2174/0115672050280894231214063023.
     PubMed     Abstract available
     
     
     
110. JIN S, Guan X, Min DY
     Evidence of Clinical Efficacy and Pharmacological Mechanisms of Resveratrol in the Treatment of Alzheimer's Disease.
     Curr Alzheimer Res. 2023 Dec 1. doi: 10.2174/0115672050272577231120060909.
     PubMed     Abstract available
     
     
     November 2023
111. MOON SW
     Neuroimaging Genetics and Network Analysis in Alzheimer's Disease Dementia.
     Curr Alzheimer Res. 2023 Nov 10. doi: 10.2174/0115672050265188231107072215.
     PubMed     Abstract available
     
     
     October 2023
112. WARREN SL, Hamza EA, Tindle R, Reid E, et al
     Common Neuropsychiatric Symptoms in Alzheimer's Disease, Mild Cognitive Impairment, and Subjective Memory Complaints: A Unified Framework.
     Curr Alzheimer Res. 2023 Oct 23. doi: 10.2174/0115672050255489231012072014.
     PubMed     Abstract available
     
     
     
113. ROY D, Kundu S, Mukherjee S
     Development of Computational Correlations among Known Drug Scaffolds and their Target-Specific Non-Coding RNA Scaffolds of Alzheimer's Disease.
     Curr Alzheimer Res. 2023 Oct 20. doi: 10.2174/0115672050261526231013095933.
     PubMed     Abstract available
     
     
     September 2023
114. ZHU XC, Zhu MZ, Lu J, Yao QY, et al
     MicroRNA-125a-3p modulate amyloid beta-protein through the MAPK pathway in Alzheimer's disease.
     Curr Alzheimer Res. 2023 Sep 13. doi: 10.2174/1567205020666230913105811.
     PubMed     Abstract available
     
     
     
115. HAN PC, Hamlett ED
     T lymphocytes in the pathogenesis and progression of Alzheimer's disease: pursuing direct neuropathological evidence.
     Curr Alzheimer Res. 2023 Sep 4. doi: 10.2174/1567205020666230904151011.
     PubMed     Abstract available
     
     
     August 2023
116. KURHAN F, Akin M
     A New Hope in Alzheimer's Disease Psychosis: Pimavanserin.
     Curr Alzheimer Res. 2023 Aug 25. doi: 10.2174/1567205020666230825124922.
     PubMed     Abstract available
     
     
     
117. SHENG C, Chu X, He Y, Ding Q, et al
     Alterations in Peripheral Metabolites as Key Actors in Alzheimer's Disease.
     Curr Alzheimer Res. 2023 Aug 25. doi: 10.2174/1567205020666230825091147.
     PubMed     Abstract available
     
     
     
118. MOLKOV YI, Zaretskaia MV, Zaretsky DV
     Integrative Theory of Alzheimer's Disease: Linking Molecular Mechanisms of Neurotoxicity, Beta-amyloid Biomarkers, and the Diagnosis.
     Curr Alzheimer Res. 2023 Aug 21. doi: 10.2174/1567205020666230821141745.
     PubMed     Abstract available
     
     
     
119. AMARAL-CARVALHO V, Bento Lima-Silva T, Inacio Mariano L, Cruz de Souza L, et al
     Predicting Dementia Due to Alzheimer's Disease and Behavioral Variant Frontotemporal Dementia Using Algorithms with the Addenbrooke's Cognitive Examination-Revised Subscores Combined with Sociodemographic Factors.
     Curr Alzheimer Res. 2023 Aug 16. doi: 10.2174/1567205020666230816160700.
     PubMed     Abstract available
     
     
     
120. YUAN W, Zhi W, Ma L, Hu X, et al
     Neural Oscillation Disorder in the Hippocampal CA1 Region of Different Alzheimer's Disease Mice.
     Curr Alzheimer Res. 2023 Aug 8. doi: 10.2174/1567205020666230808122643.
     PubMed     Abstract available
     
     
     July 2023
121. FERNANDEZ-CASTANO R, Fernandez-Blazquez MA, Echevarria-Fernandez I, Cabrera-Freitag M, et al
     Effect of Transcranial Pulse Stimulation for the Treatment of Alzheimer s Disease and its Related Symptoms.
     Curr Alzheimer Res. 2023 Jul 27. doi: 10.2174/1567205020666230727102025.
     PubMed     Abstract available
     
     
     
122. BUOITE STELLA A, Galmonte A, Deodato M, Ozturk S, et al
     Climate Change and Global Warming: Are Individuals with Dementia - including Alzheimer's Disease - at A Higher Risk?
     Curr Alzheimer Res. 2023 Jul 26. doi: 10.2174/1567205020666230726112305.
     PubMed    
     
     
     
123. GALGANI A, Palermo G, Lombardo F, Martini N, et al
     Different patterns of Locus Coeruleus MRI alteration in Alzheimer's and Dementia with Lewy bodies.
     Curr Alzheimer Res. 2023 Jul 21. doi: 10.2174/1567205020666230721144603.
     PubMed     Abstract available
     
     
     June 2023
124. KHLEIFAT KM, Al-Tawarah NM, Al-Kafaween MA, Al-Ksasbeh W, et al
     Memory Enhancing and Neurogenesis Activity of Honey Bee Venom in the Symptoms of Amnesia: Using Rats with Amnesia-like Alzheimer's Disease as a Model.
     Curr Alzheimer Res. 2023 Jun 14. doi: 10.2174/1567205020666230614143027.
     PubMed     Abstract available
     
     
     
125. LUANA CHAGAS MONTEIRO K, Gomes Dos Santos Alcantara M, Monteiro Lins Freire N, Brandao EM, et al
     BACE-1 Inhibitors Targeting Alzheimer's Disease.
     Curr Alzheimer Res. 2023 Jun 12. doi: 10.2174/1567205020666230612155953.
     PubMed     Abstract available
     
     
     
126. TIWARI V, Mishra A, Singh S, Shukla S, et al
     Caffeine improves memory and cognition via modulating neural progenitor cell survival and decreasing oxidative stress in Alzheimer's rat model.
     Curr Alzheimer Res. 2023 Jun 5. doi: 10.2174/1567205020666230605113856.
     PubMed     Abstract available
     
     
     
127. XIONG Y, Ye C, Sun R, Chen Y, et al
     Disrupted Balance of Gray Matter Volume and Directed Functional Connectivity in Mild Cognitive Impairment and Alzheimer's Disease.
     Curr Alzheimer Res. 2023 Jun 2. doi: 10.2174/1567205020666230602144659.
     PubMed     Abstract available
     
     
     
128. TARIQ R, Kansal B, Shaikh R, Datta S, et al
     Outcomes and Factors Affecting Transcranial Direct Current Stimulation in Alzheimer's Disease Patients: A Systematic Review.
     Curr Alzheimer Res. 2023 Jun 1. doi: 10.2174/1567205020666230601095957.
     PubMed     Abstract available
     
     
     May 2023
129. SHIH PY, Yong SB, Liu CM, Cheng-Chung Wei J, et al
     Is Vitamin D Supplementation a danger to potential treatments of Alzheimer's Disease Treatment?
     Curr Alzheimer Res. 2023 May 30. doi: 10.2174/1567205020666230530095421.
     PubMed    
     
     
     
130. CUI J, Chen D, Zhang J, Qin Y, et al
     Landmark Model-Based Individual Dynamic Prediction of Conversion from Mild Cognitive Impairment to Alzheimer's Disease using Cognitive Screening.
     Curr Alzheimer Res. 2023 May 26. doi: 10.2174/1567205020666230526101524.
     PubMed     Abstract available
     
     
     
131. VARSHNEY H, Siddique YH
     Pharmacological attributes of Fenugreek with special reference to Alzheimer's disease.
     Curr Alzheimer Res. 2023 May 25. doi: 10.2174/1567205020666230525154300.
     PubMed     Abstract available
     
     
     
132. EL HAJ M, Robin F, Moustafa AA, Gallouj K, et al
     Imagine yourself dancing waltz: The effect of imagination on memory in Alzheimer's disease.
     Curr Alzheimer Res. 2023 May 23. doi: 10.2174/1567205020666230523155845.
     PubMed     Abstract available
     
     
     
133. KULLENBERG H, Wibom M, Kumlin M, Nystrom T, et al
     Associations Between the Use of Metformin and Behavioral and Psychological Symptoms in Patients with Alzheimer s Disease, and Type 2 Diabetes Mellitus - a Register-Based Study.
     Curr Alzheimer Res. 2023 May 22. doi: 10.2174/1567205020666230522102641.
     PubMed     Abstract available
     
     
     
134. WEAVER DF
     The Immunopathy of Alzheimer's Disease: Innate or Adaptive?
     Curr Alzheimer Res. 2023 May 17. doi: 10.2174/1567205020666230517103312.
     PubMed     Abstract available
     
     
     
135. BOSTANCIKLIOGLU M
     Connectivity between gut microbiota and terminal awakenings in Alzheimer's disease.
     Curr Alzheimer Res. 2023 May 4. doi: 10.2174/1567205020666230504153407.
     PubMed     Abstract available
     
     
     April 2023
136. CUSTODIO N, Malaga M, Montesinos R, Chambergo D, et al
     Impact of Covid-19 Mandatory Lockdown Measures on Cognitive and Neuropsychiatric Symptoms in Persons With Alzheimer's Disease in Lima, Peru.
     Curr Alzheimer Res. 2023 Apr 17. doi: 10.2174/1567205020666230417103216.
     PubMed     Abstract available
     
     
     March 2023
137. HAMZA EA, Moustafa AA, Tindle R, Karki R, et al
     Effect of APOE4 Allele and Gender on the Rate of Atrophy in the Hippocampus, Entorhinal Cortex, and Fusiform Gyrus in Alzheimer's Disease.
     Curr Alzheimer Res. 2023 Mar 9. doi: 10.2174/1567205020666230309113749.
     PubMed     Abstract available
     
     
     
138. ZHU H, Zhu H, Liu X, Wei F, et al
     The Characteristics of Entorhinal Cortex Functional Connectivity in Alzheimer's Disease Patients with Depression.
     Curr Alzheimer Res. 2023 Mar 3. doi: 10.2174/1567205020666230303093112.
     PubMed     Abstract available
     
     
     January 2023
139. RONG G, Hongrong W, Qingqi L, Jianfeng Z, et al
     Roles of Microglia in AD Pathology.
     Curr Alzheimer Res. 2023;19:854-869.
     PubMed     Abstract available
     
     
     
140. LIU L, Hao L, Yang Q, Cao Q, et al
     Alpha Rhythm Wavelength of Electroencephalography Signals as a Diagnostic Biomarker for Alzheimer's Disease.
     Curr Alzheimer Res. 2023;20:11-28.
     PubMed     Abstract available
     
     
     
141. JIANG X, Chen L, Fu Q, Ma DL, et al
     Kidney Yang Deficiency Syndrome Exacerbates Abeta(25-35)-Induced Pathological Changes, and Ginsenoside Re Ameliorates Synapse Lesions in Abeta(25-35)- Injected Rats with Kidney Yang Deficiency Syndrome.
     Curr Alzheimer Res. 2023;20:48-58.
     PubMed     Abstract available
     
     
     
142. YADAV S, Aggarwal P, Khan F, Khodve G, et al
     beta-sitosterol Protects against Aluminium Chloride-mediated Neurotoxicity.
     Curr Alzheimer Res. 2023;20:29-37.
     PubMed     Abstract available
     
     
     
143. VEZENKOV LT, Tsekova DS, Kostadinova I, Mihaylova R, et al
     Synthesis and Biological Study of 4-Aminopyridine-Peptide Derivatives Designed for the Treatment of Neurodegenerative Disorders.
     Curr Alzheimer Res. 2023;20:120-129.
     PubMed     Abstract available
     
     
     
144. GU L, Shu H, Wang Y, Wang P, et al
     Blood Neurofilament Light Chain in Different Types of Dementia.
     Curr Alzheimer Res. 2023;20:149-160.
     PubMed     Abstract available
     
     
     
145. PERINI G, Ramusino MC, Farina LM, Fabbro BD, et al
     Cognitive Versus Hemorrhagic Onset in Cerebral Amyloid Angiopathy: Neuroimaging Features.
     Curr Alzheimer Res. 2023;20:267-276.
     PubMed     Abstract available
     
     
     
146. YOU FL, Xia GF, Cai J
     Behavioural Variant Frontotemporal Dementia due to CCNF Gene Mutation: A Case Report.
     Curr Alzheimer Res. 2023;20:371-378.
     PubMed     Abstract available
     
     
     
147. MINNE D, Marnewick JL, Engel-Hills P
     Early Chronic Stress Induced Changes within the Locus Coeruleus in Sporadic Alzheimer's Disease.
     Curr Alzheimer Res. 2023;20:301-317.
     PubMed     Abstract available
     
     
     
148. ZHOU B, Zhao Q, Kojima S, Ding D, et al
     Early Detection of Dementia using Risk Classification in MCI: Outcomes of Shanghai Mild Cognitive Impairment Cohort Study.
     Curr Alzheimer Res. 2023;20:431-439.
     PubMed     Abstract available
     
     
     
149. KAN B, Dong Z, Tang Z, Zhao L, et al
     Acupuncture Improves Synaptic Plasticity of SAMP8 Mice through the RhoA/ROCK Pathway.
     Curr Alzheimer Res. 2023;20:420-430.
     PubMed     Abstract available
     
     
     
150. KOCIOLEK AJ, Fernandez KK, Hernandez M, Jin Z, et al
     Neuropsychiatric Symptoms and Trajectories of Dependence and Cognition in a Sample of Community-dwelling Older Adults with Dementia.
     Curr Alzheimer Res. 2023;20:409-419.
     PubMed     Abstract available
     
     
     
151. ATAY LO, Saka E, Akdemir UO, Yetim E, et al
     Hybrid PET/MRI with Flutemetamol and FDG in Alzheimer's Disease Clinical Continuum.
     Curr Alzheimer Res. 2023;20:481-495.
     PubMed     Abstract available
     
     
     
152. MOLOBEKOVA CA, Kondaurova EM, Ilchibaeva TV, Rodnyy AY, et al
     Amisulpride Decreases Tau Protein Hyperphosphorylation in the Brain of OXYS Rats.
     Curr Alzheimer Res. 2023;20:496-505.
     PubMed     Abstract available
     
     
     
153. GREEN ZD, Kueck PJ, John CS, Burns JM, et al
     Blood Biomarkers Discriminate Cerebral Amyloid Status and Cognitive Diagnosis when Collected with ACD-A Anticoagulant.
     Curr Alzheimer Res. 2023;20:557-566.
     PubMed     Abstract available
     
     
     
154. KHALIFA J, Bourgault S, Gaudreault R
     Interactions of Polyphenolic Gallotannins with Amyloidogenic Polypeptides Associated with Alzheimer's Disease: From Molecular Insights to Physiological Significance.
     Curr Alzheimer Res. 2023;20:603-617.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.